SMTEF yields 34.90% · MRK yields 2.76%● Live data
📍 SMTEF pulled ahead of the other in Year 1
Combined, SMTEF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SMTEF + MRK for your $10,000?
Smart Eye AB (publ) develops eye tracking artificial intelligence technology solutions that understands, supports, and predicts human intentions and actions in Sweden and internationally. The company offers driver monitoring systems and interior sensing solutions for automotive market; and end-to-end driver monitoring systems for fleet and aftermarket. It also provides eye tracking systems for analyzing human behavior under the Smart Eye Pro, Smart Eye Pro dx, AI-X, XO, and Aurora names, as well as offers smart recorders, software, and analysis services to automotive, aviation, aerospace, neuroscience, psychology, human computer interaction research, user experience/marketing, and medicine industries. Smart Eye AB (publ) was incorporated in 1999 and is headquartered in Gothenburg, Sweden.
Full SMTEF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.